Pfizer (PFE) Stock: Investor Analysis and 2026 Outlook

In-Depth Analysis

Pfizer (PFE) is a multinational biopharmaceutical company with a diverse portfolio spanning various therapeutic areas. Recent activity in Pfizer stock includes:

**Institutional Trading:**
Jones Financial Companies Lllp increased its stake by 9.9%, holding 3,315,112 shares valued at $78.84 million.
Frank Rimerman Advisors LLC raised its position by 27.6%, owning 196,970 shares worth $5.02 million.
Teacher Retirement System of Texas increased its holdings by 32.3%, owning 2,764,113 shares valued at $70.43 million.

**Dividend Details:** Pfizer's dividend payout stands at $0.43 per share, equating to an annualized yield of approximately 6.5%. The dividend payout ratio is 100%.

**Earnings and Guidance:** In the last quarter, Pfizer reported an EPS of $0.87, exceeding estimates. The company's FY2025 guidance is set between $3.00 and $3.15 EPS.

**Analyst Sentiment:** Analyst ratings range from "Strong Buy" to "Sell," with an average rating of "Hold." Price targets vary, reflecting differing opinions on the stock's potential.

Pfizer's strategic moves, such as its $23 billion investment in oncology and a licensing agreement with Novavax, indicate a focus on long-term growth and innovation. However, some analysts caution about valuation and execution risks.

Read source article

FAQ

- **Q: What is Pfizer's current dividend yield?

- **Q: What is the analyst consensus rating for Pfizer stock?

- **Q: What was Pfizer's EPS in the most recent quarter?

Takeaways

Pfizer's stock is influenced by institutional investment trends and analyst ratings.
The company's dividend payout provides a steady yield for investors.
Strategic investments in oncology and vaccine technology could drive future growth.
Investors should consider both the potential rewards and risks associated with Pfizer stock.

Discussion

Do you think Pfizer's strategic investments will pay off in the long run? Let us know your thoughts!

Share this article with others who need to stay ahead of this trend!

Sources

Jones Financial Companies Lllp Has $78.84 Million Position in Pfizer Inc. $PFE Frank Rimerman Advisors LLC Raises Stock Position in Pfizer Inc. $PFE Pfizer Inc. $PFE Shares Purchased by Teacher Retirement System of Texas

Disclaimer

This article was compiled by Yanuki using publicly available data and trending information. The content may summarize or reference third-party sources that have not been independently verified. While we aim to provide timely and accurate insights, the information presented may be incomplete or outdated.

All content is provided for general informational purposes only and does not constitute financial, legal, or professional advice. Yanuki makes no representations or warranties regarding the reliability or completeness of the information.

This article may include links to external sources for further context. These links are provided for convenience only and do not imply endorsement.

Always do your own research (DYOR) before making any decisions based on the information presented.